| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/26/2009 | WO2008014060A3 Microparticle |
| 02/26/2009 | WO2008006712A3 Preparation of nanodispersions |
| 02/26/2009 | WO2008005458A3 Delivery device having self-assembling dendritic polymers and method of use thereof |
| 02/26/2009 | WO2007084962A3 A fluid membrane-based ligand display system for live cell assays and disease diagnosis applications |
| 02/26/2009 | WO2006083260A3 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 02/26/2009 | WO2005110407A3 Nanoparticle dispersion containing lactam compound |
| 02/26/2009 | WO2005067898A3 Improved sustained release compositions for pulmonary administration of insulin |
| 02/26/2009 | US20090054877 Acoustically controlled substance delivery device |
| 02/26/2009 | US20090054832 Administration apparatus for medical use |
| 02/26/2009 | US20090054750 Method and System for Providing Integrated Analyte Monitoring and Infusion System Therapy Management |
| 02/26/2009 | US20090054722 Drug Carrier Containing Magnetic Fine Particles and System Using the Same |
| 02/26/2009 | US20090054530 Methods and Compositions that Enhance Bioavailability of Coenzyme-Q10 |
| 02/26/2009 | US20090054499 results in little or no liver damage |
| 02/26/2009 | US20090054485 Method of treating neutrophil-related diseases with topical anesthetics |
| 02/26/2009 | US20090054481 Saquinavir Mesylate Oral Dosage Form |
| 02/26/2009 | US20090054385 Solid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090054384 Airway alkalinization as therapy for airway diseases |
| 02/26/2009 | US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
| 02/26/2009 | US20090054343 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives |
| 02/26/2009 | US20090054311 Novel Cyclosporin Analog Formulations |
| 02/26/2009 | US20090054307 Prophylactic and therapeutic agents and uses therefor |
| 02/26/2009 | US20090053707 Methods for lightening skin and hair |
| 02/26/2009 | US20090053318 Forming Embolic Particles |
| 02/26/2009 | US20090053317 Microparticulate systems for the oral administration of biologically active substances |
| 02/26/2009 | US20090053316 Nanoclusters for delivery of therapeutics |
| 02/26/2009 | US20090053315 Thermo-Kinetic Mixing for Pharmaceutical Applications |
| 02/26/2009 | US20090053314 Submicronization of proteins using supercritical fluids |
| 02/26/2009 | US20090053313 Process for the preparation of a polymeric hydrogel based on a highly purified polyvinylalcohol and uses thereof |
| 02/26/2009 | US20090053312 Methodology and Composition for a Skin Lubricant |
| 02/26/2009 | US20090053311 Pharmaceutical Compositions for Treating or Preventing Bone Conditions |
| 02/26/2009 | US20090053310 Novel sustained release dosage form |
| 02/26/2009 | US20090053309 Adhesive compositions for the treatment of xerostomia |
| 02/26/2009 | US20090053308 Release-Control Composition |
| 02/26/2009 | US20090053307 Immediate-release therapeutic systems for improved oral absorption of 7-[(e)]-t-buty-loxyminomethyl] camptothecin |
| 02/26/2009 | US20090053306 Pharmaceutical Compositions of a 5-HT2A Serotonin Receptor Modulator Useful for the Treatment of Disorders Related Thereto |
| 02/26/2009 | US20090053305 Pharmaceutical Formulations |
| 02/26/2009 | US20090053304 Composition and method of producing a taste masking formulation of laxatives for bowel cleaning preparation prior to colonoscopy |
| 02/26/2009 | US20090053303 Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes |
| 02/26/2009 | US20090053302 Cancer treatments |
| 02/26/2009 | US20090053301 Silicone vesicles containing actives |
| 02/26/2009 | US20090053300 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 02/26/2009 | US20090053299 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
| 02/26/2009 | US20090053298 constitutive active/androstane receptor (CAR); antisense agents; drug screening; hepatocytes |
| 02/26/2009 | US20090053297 Compositions and methods for less immunogenic protein-lipid complexes |
| 02/26/2009 | US20090053296 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN) |
| 02/26/2009 | US20090053295 Regulatable fusion promoters |
| 02/26/2009 | US20090053294 Anti Mineralocorticoid Therapy of Infection |
| 02/26/2009 | US20090053293 Nano Anticancer Micelles of Vinca Alkaloids Entrapped in Polyethylene Glycolylated Phospholipids |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053291 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 02/26/2009 | US20090053290 Transdermal drug delivery compositions and topical compositions for application on the skin |
| 02/26/2009 | US20090053289 Kit for the treatment of a corn or callus |
| 02/26/2009 | US20090053288 Hemostatic woven fabric |
| 02/26/2009 | US20090053286 Products and methods for maintaining or increasing ceramide levels in skin |
| 02/26/2009 | US20090053285 Medicament Carrier Composition and Method Of Forming A Film Therefrom |
| 02/26/2009 | US20090053283 such as vulvodynia via comprising administering polyarginine; for treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary disease, erectile dysfunction, Raynaud's syndrome, heparin overdose, vulvodynia, and wound healing agents |
| 02/26/2009 | US20090053281 Embolization |
| 02/26/2009 | US20090053278 Anti-microbial compositions and devices and methods of using the same |
| 02/26/2009 | US20090053276 Injectable hydrogel compositions |
| 02/26/2009 | US20090053274 Delivery system for a medicament or well-being enhancing composition |
| 02/26/2009 | US20090053272 Method for producing polymer nanoparticles |
| 02/26/2009 | US20090053271 Reverse-Phase Microcapsules for Actice Ingredients, Simplified Process of Manufacture Thereof and Combined Formulation Wdg- Cs,Zc, Ec-Sc, and Cx |
| 02/26/2009 | US20090053268 Nanoparticle modified lubricants and waxes with enhanced properties |
| 02/26/2009 | US20090053190 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer |
| 02/26/2009 | US20090053163 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 02/26/2009 | US20090053149 nonionic surfactant such as Tyloxapol in a sterile aqueous solution of an antimicrobial such as an antibiotic; phosphatide-free; aerosol drug delivery to lungs |
| 02/26/2009 | US20090053148 Toll like receptor modulators |
| 02/26/2009 | US20090053147 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 02/26/2009 | US20090053146 Metronidazole-based dermatological foams and emulsions for the preparation thereof |
| 02/26/2009 | US20090053145 Anti-viral compositions and methods of use in cattle |
| 02/26/2009 | US20090053144 Reduction in bacterial colonization by administering bacteriophage compositions |
| 02/26/2009 | US20090053143 Liquid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090050506 Fragrance sampler insert |
| 02/26/2009 | US20090049935 Stabilized milnacipran formulation |
| 02/26/2009 | DE19931077B4 Verfahrung zur Herstellung von Saurem Dialysekonzentrat Verfahrung for the preparation of acid dialysis concentrate |
| 02/26/2009 | DE102007039772A1 Mikrokapsel und Verfahren zu deren Herstellung The microcapsule and process for their preparation |
| 02/26/2009 | CA2697328A1 Antifungal composition |
| 02/26/2009 | CA2697150A1 Methods and compositions for controlling the bioavailability of poorly soluble drugs |
| 02/26/2009 | CA2697099A1 Thermo-kinetic mixing for pharmaceutical applications |
| 02/26/2009 | CA2697093A1 Use of carbon nanotube for drug delivery |
| 02/26/2009 | CA2697071A1 Film coating compositions based on tribasic calcium phosphate |
| 02/26/2009 | CA2697044A1 Liposome formulations of boronic acid compounds |
| 02/26/2009 | CA2697042A1 Liposome compositions for in vivo administration of boronic acid compounds |
| 02/26/2009 | CA2697034A1 Acid containing lipid formulations |
| 02/26/2009 | CA2696979A1 Materials and methods for treating or preventing organophosphate exposure associated damage |
| 02/26/2009 | CA2696793A1 Novel preparation for external use |
| 02/26/2009 | CA2696632A1 High concentration local anesthetic formulations |
| 02/26/2009 | CA2696523A1 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 02/26/2009 | CA2696471A1 Copolymer-stabilized emulsions |
| 02/26/2009 | CA2695451A1 Method and arrangement for forming variable color pharmaceutical products |
| 02/26/2009 | CA2694059A1 Novel method for producing dry hydrodispersible pharmaceutical forms |
| 02/26/2009 | CA2691600A1 Hyaluronic acid injectable gel for treating joint degeneration |
| 02/25/2009 | EP2028159A2 Water purification apparatus |
| 02/25/2009 | EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 02/25/2009 | EP2027865A1 Liposome having lipid membrane containing bacterial cell component |
| 02/25/2009 | EP2027852A1 Adhesive compositions for the treatment of xerostoma |
| 02/25/2009 | EP2027851A1 Topical pharmaceutical formulations and methods of treatment |
| 02/25/2009 | EP2027850A1 Pharmaceutical compositions containing voriconazole |
| 02/25/2009 | EP2026880A1 Pharmaceutical and cosmetic use of silica |
| 02/25/2009 | EP2026878A2 Photodynamic foam composition and sclerosis treatment |